JP2023541400A5 - - Google Patents

Info

Publication number
JP2023541400A5
JP2023541400A5 JP2023516171A JP2023516171A JP2023541400A5 JP 2023541400 A5 JP2023541400 A5 JP 2023541400A5 JP 2023516171 A JP2023516171 A JP 2023516171A JP 2023516171 A JP2023516171 A JP 2023516171A JP 2023541400 A5 JP2023541400 A5 JP 2023541400A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
fusion protein
acid sequence
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023516171A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023541400A (ja
JP7719172B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/049853 external-priority patent/WO2022056254A2/en
Publication of JP2023541400A publication Critical patent/JP2023541400A/ja
Publication of JP2023541400A5 publication Critical patent/JP2023541400A5/ja
Priority to JP2025123695A priority Critical patent/JP2025183960A/ja
Application granted granted Critical
Publication of JP7719172B2 publication Critical patent/JP7719172B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023516171A 2020-09-11 2021-09-10 Dna修飾酵素並びにその活性断片及びバリアント並びにその使用方法 Active JP7719172B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025123695A JP2025183960A (ja) 2020-09-11 2025-07-24 Dna修飾酵素並びにその活性断片及びバリアント並びにその使用方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063077089P 2020-09-11 2020-09-11
US63/077,089 2020-09-11
US202163146840P 2021-02-08 2021-02-08
US63/146,840 2021-02-08
PCT/US2021/049853 WO2022056254A2 (en) 2020-09-11 2021-09-10 Dna modifying enzymes and active fragments and variants thereof and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025123695A Division JP2025183960A (ja) 2020-09-11 2025-07-24 Dna修飾酵素並びにその活性断片及びバリアント並びにその使用方法

Publications (3)

Publication Number Publication Date
JP2023541400A JP2023541400A (ja) 2023-10-02
JP2023541400A5 true JP2023541400A5 (cg-RX-API-DMAC7.html) 2024-09-19
JP7719172B2 JP7719172B2 (ja) 2025-08-05

Family

ID=78087537

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023516171A Active JP7719172B2 (ja) 2020-09-11 2021-09-10 Dna修飾酵素並びにその活性断片及びバリアント並びにその使用方法
JP2025123695A Pending JP2025183960A (ja) 2020-09-11 2025-07-24 Dna修飾酵素並びにその活性断片及びバリアント並びにその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025123695A Pending JP2025183960A (ja) 2020-09-11 2025-07-24 Dna修飾酵素並びにその活性断片及びバリアント並びにその使用方法

Country Status (11)

Country Link
US (9) US12398384B2 (cg-RX-API-DMAC7.html)
EP (1) EP4211235A2 (cg-RX-API-DMAC7.html)
JP (2) JP7719172B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230084505A (cg-RX-API-DMAC7.html)
AU (1) AU2021339805A1 (cg-RX-API-DMAC7.html)
CA (1) CA3173886A1 (cg-RX-API-DMAC7.html)
IL (1) IL301139A (cg-RX-API-DMAC7.html)
MX (1) MX2023002848A (cg-RX-API-DMAC7.html)
TW (2) TWI910226B (cg-RX-API-DMAC7.html)
WO (1) WO2022056254A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA202304237B (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019217942A1 (en) 2018-05-11 2019-11-14 Beam Therapeutics Inc. Methods of substituting pathogenic amino acids using programmable base editor systems
KR20210055733A (ko) 2018-09-07 2021-05-17 빔 테라퓨틱스, 인크. 핵염기 편집 시스템을 전달하기 위한 조성물 및 방법
EP3850088A4 (en) 2018-09-07 2023-07-19 Beam Therapeutics, Inc. Compositions and methods for improving base editing
JP7646552B2 (ja) 2019-01-31 2025-03-17 ビーム セラピューティクス インク. 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ
US12600971B2 (en) 2019-02-13 2026-04-14 Beam Therapeutics Inc. Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
WO2020168135A1 (en) 2019-02-13 2020-08-20 Beam Therapeutics Inc. Compositions and methods for treating alpha-1 antitrypsin deficiency
WO2020191241A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US12594301B2 (en) 2019-09-27 2026-04-07 Beam Therapeutics Inc. Compositions and methods for treatment of liquid cancers
AU2021347359A1 (en) 2020-09-25 2023-05-18 Beam Therapeutics Inc. Fratricide resistant modified immune cells and methods of using the same
CA3173953A1 (en) 2021-06-11 2023-12-10 Tyson D. BOWEN Rna polymerase iii promoters and methods of use
CN114634923B (zh) * 2022-04-07 2024-02-23 尧唐(上海)生物科技有限公司 腺苷脱氨酶、碱基编辑器融合蛋白、碱基编辑器系统及用途
CN114686456B (zh) 2022-05-10 2023-02-17 中山大学 基于双分子脱氨酶互补的碱基编辑系统及其应用
AU2023323547A1 (en) 2022-08-12 2025-03-20 Life Edit Therapeutics, Inc. Rna-guided nucleases and active fragments and variants thereof and methods of use
WO2024042489A1 (en) 2022-08-25 2024-02-29 LifeEDIT Therapeutics, Inc. Chemical modification of guide rnas with locked nucleic acid for rna guided nuclease-mediated gene editing
IL320573A (en) 2022-11-04 2025-07-01 Life Edit Therapeutics Inc Developed adenine deaminases and RNA-guided nuclease fusion proteins with internal insertion sites and methods of use
WO2024127370A1 (en) 2022-12-16 2024-06-20 LifeEDIT Therapeutics, Inc. Guide rnas that target trac gene and methods of use
WO2024127369A1 (en) 2022-12-16 2024-06-20 LifeEDIT Therapeutics, Inc. Guide rnas that target foxp3 gene and methods of use
WO2024178397A2 (en) 2023-02-24 2024-08-29 Elevatebio Technologies, Inc. Modified immune effector cells and methods of use
CN117965505A (zh) * 2023-06-28 2024-05-03 微光基因(苏州)有限公司 工程化的腺苷脱氨酶及碱基编辑器
EP4750890A2 (en) 2023-07-27 2026-06-03 Life Edit Therapeutics, Inc. Rna-guided nucleases and active fragments and variants thereof and methods of use
CN122422501A (zh) 2023-10-18 2026-07-17 生命编辑治疗股份有限公司 Rna引导的核酸酶及其活性片段和变体以及使用方法
CN122161928A (zh) 2023-10-25 2026-06-05 上海尧唐生物科技股份有限公司 一种脱氨酶、包含其的碱基编辑器及其应用
WO2025122725A1 (en) * 2023-12-06 2025-06-12 The Broad Institute, Inc. Methods and compositions for base editing of tpp1 in the treatment of batten disease
CN117511912B (zh) * 2023-12-22 2024-03-29 辉大(上海)生物科技有限公司 IscB多肽、包含其的系统及其用途
WO2025174908A1 (en) 2024-02-12 2025-08-21 Life Edit Therapeutics, Inc. Novel rna-guided nucleases and proteins for polymerase editing
WO2025206105A1 (ja) * 2024-03-29 2025-10-02 株式会社Frest 標的アデノシンに対する部位特異的編集を誘導するオリゴヌクレオチド
TW202617985A (zh) 2024-06-25 2026-05-01 美商生命編輯治療學公司 新穎反轉錄酶及其用途
WO2026143185A1 (en) 2024-12-23 2026-07-02 Ensoma Aps Engineered rna-guided dna-binding polypeptides

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217344A (en) 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4186183A (en) 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US4485054A (en) 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5380831A (en) 1986-04-04 1995-01-10 Mycogen Plant Science, Inc. Synthetic insecticidal crystal protein gene
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5049386A (en) 1985-01-07 1991-09-17 Syntex (U.S.A.) Inc. N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5569597A (en) 1985-05-13 1996-10-29 Ciba Geigy Corp. Methods of inserting viral DNA into plant material
US4774085A (en) 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4853331A (en) 1985-08-16 1989-08-01 Mycogen Corporation Cloning and expression of Bacillus thuringiensis toxin gene toxic to beetles of the order Coleoptera
US5268463A (en) 1986-11-11 1993-12-07 Jefferson Richard A Plant promoter α-glucuronidase gene construct
US5608142A (en) 1986-12-03 1997-03-04 Agracetus, Inc. Insecticidal cotton plants
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5039523A (en) 1988-10-27 1991-08-13 Mycogen Corporation Novel Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
KR920701453A (ko) 1989-03-17 1992-08-11 미리엄 디. 멕코나헤이 유전자발현의 외부조절
ES2187497T3 (es) 1990-04-12 2003-06-16 Syngenta Participations Ag Promotores preferentemente en tejidos.
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
AU7979491A (en) 1990-05-03 1991-11-27 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5498830A (en) 1990-06-18 1996-03-12 Monsanto Company Decreased oil content in plant seeds
CA2051562C (en) 1990-10-12 2003-12-02 Jewel M. Payne Bacillus thuringiensis isolates active against dipteran pests
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5399680A (en) 1991-05-22 1995-03-21 The Salk Institute For Biological Studies Rice chitinase promoter
JPH06510187A (ja) 1991-08-27 1994-11-17 ノバルティス アクチエンゲゼルシャフト 同翅類昆虫に対する殺虫性質を有したタンパク質及び植物保護におけるそれらの用法
TW261517B (cg-RX-API-DMAC7.html) 1991-11-29 1995-11-01 Mitsubishi Shozi Kk
US5587308A (en) 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
US5789156A (en) 1993-06-14 1998-08-04 Basf Ag Tetracycline-regulated transcriptional inhibitors
US5814618A (en) 1993-06-14 1998-09-29 Basf Aktiengesellschaft Methods for regulating gene expression
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5608144A (en) 1994-08-12 1997-03-04 Dna Plant Technology Corp. Plant group 2 promoters and uses thereof
US5659026A (en) 1995-03-24 1997-08-19 Pioneer Hi-Bred International ALS3 promoter
US6072050A (en) 1996-06-11 2000-06-06 Pioneer Hi-Bred International, Inc. Synthetic promoters
ES2270227T3 (es) 1998-02-26 2007-04-01 Pioneer Hi-Bred International, Inc. Promotor met-1 del maiz.
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
CN1360632A (zh) 1999-05-04 2002-07-24 孟山都技术有限公司 鞘翅目毒性多肽组合物和抗虫转基因植物
BR0014516A (pt) 1999-09-15 2002-07-02 Monsanto Technology Llc Composições e métodos de uso de delta-endotoxina do bacilo thuringiensis ativo de lepidopteran
US20050183161A1 (en) 2003-10-14 2005-08-18 Athenix Corporation AXMI-010, a delta-endotoxin gene and methods for its use
US7629504B2 (en) 2003-12-22 2009-12-08 Pioneer Hi-Bred International, Inc. Bacillus thuringiensis cry9 nucleic acids
ES2397118T3 (es) 2006-06-14 2013-03-04 Athenix Corporation AXMI-031, AXMI-039 ,AXMI-040 y AXMI-049, una familia de genes de endotoxina delta y métodos para su uso
CN102648281B (zh) 2009-07-02 2017-04-05 阿森尼克斯公司 Axmi‑205杀虫基因和它的使用方法
US8586832B2 (en) 2009-12-21 2013-11-19 Pioneer Hi Bred International Inc Bacillus thuringiensis gene with Lepidopteran activity
CN103154247A (zh) 2010-08-19 2013-06-12 先锋国际良种公司 对鳞翅目昆虫具有活性的新苏云金杆菌基因
US9405700B2 (en) 2010-11-04 2016-08-02 Sonics, Inc. Methods and apparatus for virtualization in an integrated circuit
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
US10450584B2 (en) 2014-08-28 2019-10-22 North Carolina State University Cas9 proteins and guiding features for DNA targeting and genome editing
AU2016226077B2 (en) 2015-03-03 2021-12-23 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases with altered PAM specificity
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
AU2019282149B2 (en) 2018-06-05 2025-08-21 Life Edit Therapeutics, Inc. RNA-guided nucleases and active fragments and variants thereof and methods of use
CA3125175A1 (en) * 2018-12-27 2020-07-02 LifeEDIT Therapeutics, Inc. Polypeptides useful for gene editing and methods of use
CN113631704A (zh) * 2018-12-27 2021-11-09 生命编辑制药股份有限公司 可用于基因编辑的多肽及使用方法
WO2020181195A1 (en) 2019-03-06 2020-09-10 The Broad Institute, Inc. T:a to a:t base editing through adenine excision
CN118813654A (zh) 2019-08-12 2024-10-22 生命编辑制药股份有限公司 Rna指导的核酸酶及其活性片段及变体以及使用方法

Similar Documents

Publication Publication Date Title
JP2024137967A5 (cg-RX-API-DMAC7.html)
JP2024083479A5 (cg-RX-API-DMAC7.html)
CN113373130A (zh) Cas12蛋白、含有Cas12蛋白的基因编辑系统及应用
Hümbelin et al. Type III DNA restriction and modification systems EcoP1 and EcoP15: Nucleotide sequence of the EcoP1 operon, the EcoP15mod gene and some EcoP1mod mutants
JP2023516226A5 (cg-RX-API-DMAC7.html)
JP2019536425A5 (cg-RX-API-DMAC7.html)
FI4118198T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja käyttömenetelmiä
CA3228222A1 (en) Class ii, type v crispr systems
US10883091B2 (en) DNA polymerase variant and application thereof
CN102796728A (zh) 用于通过转座酶的dna片段化和标记的方法和组合物
JP2022522650A5 (cg-RX-API-DMAC7.html)
JP2019534695A5 (cg-RX-API-DMAC7.html)
JP2023156365A5 (cg-RX-API-DMAC7.html)
AU2020278864B2 (en) Single base substitution protein, and composition comprising same
JP2022541273A5 (cg-RX-API-DMAC7.html)
JP2025504898A5 (cg-RX-API-DMAC7.html)
JP2022530055A5 (cg-RX-API-DMAC7.html)
JP2023536408A5 (cg-RX-API-DMAC7.html)
AR125191A1 (es) Enzimas modificadoras del adn y sus fragmentos activos y variantes y métodos de uso
JP2023515670A5 (cg-RX-API-DMAC7.html)
JP2024531607A5 (cg-RX-API-DMAC7.html)
CN108795900A (zh) Dna聚合酶及其制备方法
JP2024534856A5 (cg-RX-API-DMAC7.html)
Macias et al. Biology of Trypanosoma cruzi retrotransposons: from an enzymatic to a structural point of view
JP2025535373A5 (cg-RX-API-DMAC7.html)